| Key Points: – Olipop raised $50 million in a Series C funding round, valuing the prebiotic soda brand at $1.85 billion as it competes with rivals such as Poppi. – Olipop is now the top nonalcoholic beverage brand in the U.S., both by dollar sales and unit growth, according to data from Circana/SPINS. – The company is now profitable, with annual sales surpassing $400 million last year. |
Prebiotic soda brand Olipop announced Wednesday that it had secured a $50 million investment in its latest Series C funding round, bringing its valuation to an impressive $1.85 billion. The funding marks a significant milestone for the brand, which has been rapidly growing in the competitive functional beverage market.
Founded in 2018, Olipop has played a pivotal role in popularizing prebiotic sodas, offering consumers a gut-health-focused alternative to traditional soft drinks. Alongside competitor Poppi, Olipop has successfully tapped into the wellness trend sweeping the beverage industry, positioning itself as a healthier alternative to mainstream sodas.
The latest investment round was led by J.P. Morgan Private Capital’s Growth Equity Partners, reflecting strong investor confidence in the brand’s future. Olipop intends to use the fresh capital to expand its product lineup, increase marketing efforts, and enhance distribution channels, ensuring wider availability of its sodas across the U.S. and beyond.
A Market Leader in Functional Beverages
Olipop has swiftly risen to dominance, becoming the top nonalcoholic beverage brand in the U.S. based on both dollar sales and unit growth, according to Circana/SPINS data. The company reports that approximately half of its growth stems from consumers switching from traditional soda brands, while the other half comes from new entrants into the carbonated beverage market. Notably, one in four Gen Z consumers has tried Olipop, highlighting its appeal among younger demographics.
A key factor in Olipop’s success has been its strategic branding and marketing, which emphasize its natural ingredients and gut-health benefits. The brand’s product formulations incorporate prebiotic fibers, botanicals, and plant-based ingredients, catering to health-conscious consumers seeking flavorful yet functional beverages.
Financial Growth and Profitability
Olipop reached profitability in early 2024, a significant achievement for a relatively young brand. Annual sales exceeded $400 million last year, doubling from the previous year. This rapid financial growth has attracted attention from major players in the beverage industry, with Olipop’s founder and CEO Ben Goodwin revealing that soda giants PepsiCo and Coca-Cola have already expressed interest in potential acquisition deals.
Competition and Industry Trends
Despite Olipop’s success, competition in the prebiotic soda space remains fierce. Poppi, a direct rival founded a decade ago, has also seen substantial growth. The company had raised $39.3 million as of 2023 at an undisclosed valuation, and its annual sales reportedly surpassed $100 million last year. Poppi gained widespread recognition with its Super Bowl advertisements in consecutive years, solidifying its presence in the category.
However, Poppi has faced challenges, including legal scrutiny over its health claims. The company is currently negotiating a settlement in a lawsuit alleging that its marketing misrepresented the true health benefits of its beverages.
As the functional beverage market continues to expand, Olipop’s latest funding round positions it strongly for future growth, allowing it to scale operations and maintain its leadership in the rapidly evolving industry.